Adrian Bot, KitePharma, Los Angeles, CA, USA
  Anne Plant, National Institute of Standards and Technology, Gaithersburg, MD USA
  Ashley Xia, NIAID, NIH, Bethesda, MD, USA
  Bart Roep, Leiden University Medical Centre, The Netherlands
  Cecile Gouttefangeas, University of Tübingen, Germany
  Cedrik M. Britten, Johannes Gutenberg-University, Mainz, Germany
  Chris Taylor, The European Bioinformatics Institute, UK
  Christian Ottensmeier, Southampton University Hospitals, UK
  Craig Slingluff, University of Virginia, USA
  Ena Wang, CHI, NIH, Bethesda, MD, USA
  Franco Marincola, CHI,NIH, Bethesda, MD, USA
  Graham Pawelec, University of Tübingen, Germany
  Guido Ferrari, Duke University, Durham, NC, USA
  Holden T. Maecker, Stanford University Medical Center, Stanford, CA, USA
  James Allison, MSKCC, New York, NY, USA
  James Gulley, NCI, NIH, Bethesda, MD, USA
  Janet Siebert, Cytoanalytics, USA
  Jedd Wolchok, MSKCC, New York, NY, USA
  Jeffrey Weber, Moffitt Cancer Center, Tampa FL, USA
  Jonathan Braun, UCLA, Los Angeles, CA, USA
  Josephine Cox, IAVI, Rockville, MD, USA
  Kunle Odunsi, Roswell Park, Buffalo, NY, USA
  Lisa Butterfield, University of Pittsburgh Cancer Institute, PA, USA
  Mario Roederer, VRC, NIH, USA
  Mark M. Davis, HHMI, Stanford University School of Medicine, Stanford, CA, USA
  Maurice O’Gorman, The Children’s Memorial Hospital Chicago, IL, USA
  Michael Kalos, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
  Padmanee Sharma, MD Anderson Cancer Center, Houston, TX, USA
  Patricia D’Souza, NIAID, NIH, Bethesda, MD, USA
  Peter Gottlieb, University of Colorado, USA
  Peter T. Lee, Immunity, Cambridge, MA, USA
  Ronald Rooke, Transgene, Illkirch Graffenstaden, France
  Sacha Gnjatic, LICR, MSKCC, New York, NY, USA
  Samir Khleif, NCI, NIH, Bethesda, MD, USA
  Simone Joosten, Leiden University, The Netherlands
  Sjoerd Van Der Burg, Leiden University, The Netherlands
  Steffen Walter, Immatics, Tübingen, Germany
  Sudeepta Aggarwal, Immune Tolerance Network, Bethesda, MD, USA
  Sylvia Janetzki, ZellNet Consulting, Inc., Fort Lee, NJ, USA
  Tom H. M. Ottenhoff, Leiden University Medical Center, The Netherlands

  Adrian Bot, Kitepharma, Los Angeles, CA, USA
  Alexander Knuth, University Hospital Zürich, Zürich, Switzerland
  Alexander Shimabukuro-Vornhagen, Universitaetsklinik Koeln, Koeln, Germany
  Anatoli Malyguine, SAIC-Frederick, Inc. NCI-Frederick, Frederick, MD, USA
  Ann Mander, Southampton University Hospitals, Southampton, UK
  Anne L. Plant, National Institute of Standards and Technology, Gaithersburg, MD, USA
  Arthur A. Vandenbark, Oregon Health & Science University, Portland, OR, USA
  Aubrey Watson, Alphavax, Inc., RTP, NC, USA
  Bart Roep, Leiden University Medical Centre, Leiden, The Netherlands
  Carlota Dobaño, Univeristy de Barcelona, Barcelona, Spain
  Cassian Yee, Fred Hutchinson Cancer Research Center, Seattle, USA
  Cecile Gouttefangeas, University of Tübingen, Tübingen, Germany
  Cedrik Britten, University of Mainz, Mainz, Germany
  Chris Taylor, The European Bioinformatics Institute, Cambridge, UK
  Christian Ottensmeier, Southampton University Hospitals, Southampton, UK
  Christine Bain, Transgene SA, Illkirch Graffenstaden, France
  Cristina Musselli, Agenus, Lexington, MA, USA
  Daniel Speiser, Ludwig Institute for Cancer Research,

  Darien Toledo Santamaría, Center of Molecular Immunology, Havana, Cuba
  Dolores Schendel, Helmholtz Zentrum München, München, Germany
  Dominic Warrino, ViraCor IBT-Laboratories, Lenexa, KS, USA
  Eckhard Kämpgen, Unversity of Erlangen, Erlangen, Germany
  Elizabeth Reap, Duke University, Durham, NC, USA
  Fiona Powell, University of Sussex, Brighton, UK
  Florian Kern, University of Sussex, Brighton, UK
  Francesco M Marincola, National Institutes of Health, Bethesda, MD, USA
  Gary Archer, Duke University, Durham, NC, USA
  Gerold Schuler, Unversity of Erlangen, Erlangen, Germany
  Graham Pawelec, University of Tübingen, Tübingen, Germany
  Guido Ferrari, Duke University Medical Center, Tübingen, USA
  Hans-Georg Rammensee, University of Tübingen, Tuebingen, Germany
  Heinz Zwierzina, Innsbruck Medical University, Innsbruck, Austria
  Henrik Pedersen, Immudex, Copenhagen, Denmark
  Hiroyoshi Nishikawa, Mie University Graduate School of Medicine, Mie, Japan
  Holden Maecker, Stanford University, Stanford, CA, USA
  Holger Wenschuh, JPT, Berlin, Germany
  Hugues JM Nicolay, University Hospital of Siena, Siena, Italy
  Ian Davis, LICR, Heidelberg, Victoria, Australia
  Jacqueline Smith, Dartmouth Medical School, Lebanon, NH, USA
  James Allison, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
  James L. Gulley, Center for Cancer Research, Bethesda, MD, USA
  Janet Siebert, Cytoanalytics, Denver, CO, USA
  Janet Staats, Duke University, Durham, NC, USA
  Jedd Wolchok, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
  Jeffrey Weber, Moffitt Cancer Center, Tampa, Fl, USA
  Jianda Yuan, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
  Jim Lane VRC/NIAID, NIAID, Bethesda, MD, USA
  Joanne Parker, ViraCor IBT-Laboratories, Lenexa, KS, USA
  John Hural, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
  Jonathan Cebon, LICR, Heidelberg, Victoria, Australia
  Josephine H Cox, International AIDS Vaccine Initiative, Rockville, MD, USA
  Julie Nielsen, BC Cancer Agency, Victoria, BC, Canada
  Kimberly Shafer-Weaver, SAIC-Frederick, Inc. NCI-Frederick, Frederick, MD, USA
  Kunle Odunsi, Roswell Park Cancer Institute, Buffalo, USA
  Laurence Zitvogel, Institut Gustave Roussy, Villejuif, France
  Leif Håkansson, University Hospital Linkoeping, Linkoeping, Sweden
  Licia Rivoltini, Istituto Nazionale Tumori, Milano, Italy
  Lisa Butterfield, University of Pittsburgh Cancer Center, Pittsburgh, PA, USA
  Liselotte Brix, Immudex, Copenhagen, Denmark
  Marcella Sarzotti-Kelsoe, Duke University, Nurham, NC, USA
  Marcelo Navarrete, Universitätsklinikum Freiburg, Freiburg, Germany
  Maries van den Broek, University Hospital Zürich, Zürich, Switzerland
  Marij JP Schoenmaekers-Welters, Leiden University Medical Center, Leiden, The Netherlands
  Mario Roederer, VRC, NIH, Bethesda, MD, USA
  Markus Mäurer, Karolinska Institute, Stockholm, Sweden
  Matthew Albert, Pasteur Institute, Paris, France
  Michael von Bergwelt -Baildon, University of Koeln, Koeln, Germany
  Michael Kalos, University of Pennsylvania, Philadelphia, PA, USA
  Michele Maio, University Hospital of Siena, Siena, Italy
  Nathalie Blachere, Rockefeller University, New York, NY, USA
  Padmanee Sharma, The University of Texas M. D. Anderson Cancer Center, Houston, USA
  Pamela Norberg, Duke University., Durham, NC, USA
  Paola Nistico, Regina Elena National Cancer Institute, Rome, Italy
  Patricia D’Souza, NIAID, NIH, Bethesda, MD, USA
  Paul V. Lehmann, Cellular Technology Ltd., Shaker Heights, OH, USA
  Per Thor Straten, University Hospital Herlev, Herlev, Denmark
  Philip Greenberg, University of Washington, Seattle, USA
  Regina Mendrzyk, Immatics, Tübingen, Germany
  Richard Scheuerman, UT Southwestern Medical Center, Dallas, TX, USA
  Robert Schmittling, Duke University, Durham, NC, USA
  Ronald Rooke, Transgene SA, Illkirch Graffenstaden, France
  Ryan Brinkman, BC Cancer Agency, Victoria, BC, Canada
  Sacha Gnjatic, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
  Sebastian Attig, Johannes Gutenberg-University Mainz, Mainz, Germany
  Sebastian Kreiter, Johannes Gutenberg-University Mainz, Mainz, Germany
  Shane Larson, Genocea, Cambridge, MA, USA
  Simone Joosten, Leiden University Medical Center, Leiden, The Netherlands
  Sine Hardrup, University Hospital Herlev, Herlev, Denmark
  Sjoerd H. van der Burg, Leiden University Medical Center, Leiden, The Netherlands
  Smita Nair, Duke University, Durham, NC, USA
  Sofija Andjelic, Regeneron, Inc., Tarrytown, NY, USA
  Staffan Paulie, Mabtech, Nacka Strand, Sweden
  Stefanie Groß, Unversity of Erlangen, Erlangen, Germany
  Steffen Walter, Immatics, Tübingen, Germany
  Stephen Man, Cardiff University School of Medicine, Cardiff, UK
  Steven Smith, London School of Hygiene and Tropical Medicine, London, UK
  Sylvia Janetzki, ZellNet Consulting, Fort Lee, NJ, USA
  Tania Køllgaard, Univeristy Hospital Herlev, Herlev, Denmark
  Tina Dalgaard, Aarhus University, Tjele, Denmark
  Tom H. M. Ottenhoff, Leiden University Medical Center, Leiden, The Netherlands
  Ugur Sahin, Johannes Gutenberg-University Mainz, Mainz, Germany
  Uri Lopatin, Roche, Palo Alto, CA, USA
  Venky Ramakrishna, Celldex Therapeutics, Phillipsburg, NJ, USA
  Victor Appay, Université Pierre et Marie Curie-Paris 6, Paris, France
  Vincenzo Cerundolo, University of Oxford, Oxford, UK
  Weisan Chen, LICR, Heidelberg, Victoria, Australia
  Zaima Mazorra Herrera, Center of Molecular Immunology, Havana, Cuba